House
GuidelinesCalculatorsPricingBlog
Ask House ↗
Guidelines↗Calculators↗Pricing↗Blog↗
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House
Back to guidelines
Paediatrics

Urinary tract infection in under 16s: diagnosis and management

NICE · 2022 edition / updateSource checked 29 October 2026
Read the source publication
House clinical summary

Scope

NICE guidance for UTI in children combines prompt illness assessment, reliable urine sampling, age-specific test interpretation and selective imaging. Management also addresses bowel and bladder habits and targets specialist follow-up to recurrence or renal abnormalities. Antibiotic agents and doses sit in separate antimicrobial guidelines and are not inferred here.

Written by House with AI assistance · AI-assisted source check 29 October 2026.

This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.

Use symptoms and illness severity to decide testing and referral

  • Test urine when symptoms or signs raise the likelihood of UTI, and consider testing an unwell child when suspicion remains even without a listed feature. Use the overall pattern and clinical judgement rather than a single isolated finding. [1]
  • Immediately refer a baby below 3 months with suspected UTI to paediatric specialist care, sending urine for urgent microscopy and culture. Specialist management includes parenteral antibiotics. [1]
  • Immediately refer a child at high risk of serious illness, and use the appropriate sepsis or neonatal-infection pathway when those conditions are suspected. [1]

Obtain a useful specimen without delaying urgent treatment

  • Collect urine before antibiotics whenever possible. In a seriously ill child, do not delay treatment because a sample cannot yet be obtained. [1]
  • Use clean catch where possible. If this is not feasible, use an appropriate noninvasive collection method such as a collection pad according to its instructions; do not use cotton wool, gauze or sanitary towels. [1]
  • Use catheterisation or suprapubic aspiration if noninvasive collection is impractical. Confirm urine in the bladder by ultrasound before suprapubic aspiration. [1]
  • If culture cannot occur within 4 hours, refrigerate promptly or preserve with boric acid. Follow the product’s specimen-volume instructions to avoid inhibiting bacteria in the sample. [1]

Interpret urine tests in an age-specific clinical context

  • Between 3 months and 3 years, if both leukocyte esterase and nitrite are negative, do not give antibiotics or routinely send culture unless a listed culture indication applies. If either is positive, send culture and treat. [1]
  • For children aged at least 3 years, both dipstick markers positive supports antibiotic treatment; a positive nitrite with negative leukocyte esterase also supports treatment if the specimen is fresh and should prompt culture. [1]
  • For children aged 3 years or older, isolated leukocyte esterase requires microscopy and culture, with antibiotics only if clinical evidence supports UTI. If both markers are negative, look for another cause; clinical judgement remains important when tests and symptoms conflict. [1]
  • Send culture for suspected upper UTI, high or intermediate risk of serious illness, age below 3 months, a positive dipstick, recurrence, failure to respond within 24–48 hours or clinical-test disagreement. [1]

Differentiate the syndrome and prevent avoidable recurrence

  • Bacteriuria with fever of at least 38°C, or lower fever with loin pain or tenderness, supports upper UTI. Bacteriuria without systemic symptoms supports lower UTI. Do not use C-reactive protein alone to distinguish the two. [1]
  • For children over 3 months, use the separate upper- or lower-UTI antimicrobial guideline as appropriate, and consider specialist referral for upper UTI. Do not treat asymptomatic bacteriuria with antibiotics. [1]
  • Address constipation and dysfunctional elimination, encourage adequate water intake, and ensure toilet access so the child need not postpone voiding unnecessarily. [1]
  • Do not routinely prescribe prophylaxis after a first UTI, and do not give it for asymptomatic bacteriuria. Recurrent infection needs its separate prophylaxis assessment. [1]

Select imaging by age and atypical or recurrent infection

  • Perform urinary ultrasound during an atypical infection to look for abnormalities such as obstruction. Atypical features include serious illness, poor urine flow, a mass, raised creatinine, septicaemia, non-E. coli infection or failure to respond within 48 hours. If non-E. coli infection is the only atypical feature and the child responds well to antibiotics, a nonurgent ultrasound within 6 weeks can be requested instead. [1]
  • For a baby below 6 months with a first UTI that responds to treatment, arrange ultrasound within 6 weeks. In children over 6 months who respond to a first episode, ultrasound is not routine unless infection is atypical. [1]
  • Use the age- and infection-pattern-specific imaging tables for DMSA and cystourethrography decisions. Do not routinely image solely to identify vesicoureteral reflux after every UTI, and do not routinely use surgery to manage reflux. [1]

Target follow-up to abnormalities and recurrent infection

  • Refer recurrent UTI or abnormal imaging to a paediatric specialist. Bilateral renal abnormalities, impaired function, hypertension or proteinuria require paediatric nephrology monitoring and management. [1]
  • For renal parenchymal defects, assess height, weight, blood pressure and proteinuria. Minor unilateral defects do not need long-term follow-up unless recurrence or hypertension-related family or lifestyle risks are present. [1]
  • Do not routinely retest urine once the child is asymptomatic. Give families written results and advice about recurrence, prompt recognition and seeking early treatment for suspected reinfection. [1]

Limitations and use

  • The complete age-specific DMSA and cystourethrography matrix is not reproduced. Consult the source tables before selecting these investigations.
  • This guideline does not supply the full antibiotic regimen for children with significant pre-existing uropathy or replace neonatal infection and sepsis guidance.
  • The source retains older recommendations alongside its later diagnostic update; source date is not evidence that every individual recommendation was newly reviewed.

This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.

Summary sources

  1. 1
    Urinary tract infection in under 16s: diagnosis and management

    Selected recommendation material consulted

Clinical guideline

Publication details

Issuing organisation
NICE
First published
27 July 2022
Resource type
Clinical guideline · House clinical summary
Source setting
United Kingdom

The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.

On this page

  • Scope
  • Use symptoms and illness severity to decide testing and referral
  • Obtain a useful specimen without delaying urgent treatment
  • Interpret urine tests in an age-specific clinical context
  • Differentiate the syndrome and prevent avoidable recurrence
  • Select imaging by age and atypical or recurrent infection
  • Target follow-up to abnormalities and recurrent infection
  • Limitations and use
  • Summary sources
  • Publication details
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House